Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand
- Written by PR Newswire Asia - Daily Bulletin Au RSS
![]() |
- Submission to New Zealand's Medsafe marks the first protein-based COVID-19 vaccine submitted for authorization to regulatory authorities in New Zealand
- All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for Medsafe
GAITHERSBURG, Md., Nov. 3, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq:...
Read more: Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand





